Kylea Tink (North Sydney, Independent) Share this | Hansard source

My question is to the Minister for Health and Aged Care. My constituent Paul Whitman has mantle cell lymphoma, but the therapy he needs, CAR T-cell therapy, is not funded for his condition. The therapy is already accessed by Australians with other conditions, and it was recommended by the Medical Services Advisory Committee for treatment of mantle cell lymphoma two years ago. Consequently, we have a system that delivers inequitable access to life-saving treatments. Why is this therapy being withheld from patients like Paul?

See this speech in context